Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Barbara Pro; Ranjana H Advani; Pauline Brice; Nancy L Bartlett; Joseph D Rosenblatt; Tim Illidge; Jeffrey Matous; Radhakrishnan Ramchandren; Michelle A Fanale; Joseph M. Connors; Keenan Fenton; Dirk Huebner; Juan Pinelli; Andrei R. Shustov

doi:10.1182/BLOOD.V128.22.4144.4144

Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Barbara Pro
, Ranjana H Advani
, Pauline Brice
, Nancy L Bartlett
, Joseph D Rosenblatt
, Tim Illidge
, Jeffrey Matous
, Radhakrishnan Ramchandren
, Michelle A Fanale
, Joseph M. Connors
, Keenan Fenton
, Dirk Huebner
, Juan Pinelli
, Andrei R. Shustov

Northwestern University
Stanford University
Hematology, AP-HP Hopital Saint-Louis, Paris, France
Washington University in St. Louis
University of Miami
Christie Hospital NHS, Manchester, United Kingdom
Colorado Blood Cancer Institute, Denver, CO
Karmanos Cancer Institute, Detroit, MI
University of Texas MD Anderson Cancer Center
BC Cancer Agency
Seattle Genetics
Millennium Pharmaceuticals
University of Washington Medical Center

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	128
Issue number	22
DOIs	https://doi.org/10.1182/BLOOD.V128.22.4144.4144
State	Published - Dec 6 2014
Externally published	Yes

Disciplines

Immunology and Infectious Disease
Medicine and Health Sciences
Internal Medicine

Access to Document

10.1182/BLOOD.V128.22.4144.4144License: Unspecified

Cite this

Pro, B., Advani, R. H., Brice, P., Bartlett, N. L., Rosenblatt, J. D., Illidge, T., Matous, J., Ramchandren, R., Fanale, M. A., Connors, J. M., Fenton, K., Huebner, D., Pinelli, J., & Shustov, A. R. (2014). Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma. Blood, 128(22). https://doi.org/10.1182/BLOOD.V128.22.4144.4144

Pro, B, Advani, RH, Brice, P, Bartlett, NL, Rosenblatt, JD, Illidge, T, Matous, J, Ramchandren, R, Fanale, MA, Connors, JM, Fenton, K, Huebner, D, Pinelli, J & Shustov, AR 2014, 'Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma', Blood, vol. 128, no. 22. https://doi.org/10.1182/BLOOD.V128.22.4144.4144

@article{1454fd0b08d345f9b2a9575c6e7a8b3f,

title = "Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma",

author = "Barbara Pro and Advani, \{Ranjana H\} and Pauline Brice and Bartlett, \{Nancy L\} and Rosenblatt, \{Joseph D\} and Tim Illidge and Jeffrey Matous and Radhakrishnan Ramchandren and Fanale, \{Michelle A\} and Connors, \{Joseph M.\} and Keenan Fenton and Dirk Huebner and Juan Pinelli and Shustov, \{Andrei R.\}",

note = "624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster III | Barbara Pro, Ranjana H Advani, Pauline Brice, Nancy L Bartlett, Joseph D Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan Pinelli, Andrei R.",

year = "2014",

month = dec,

day = "6",

doi = "10.1182/BLOOD.V128.22.4144.4144",

language = "American English",

volume = "128",

journal = "Blood",

publisher = "American Society of Hematology",

number = "22",

}

TY - JOUR

T1 - Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

AU - Pro, Barbara

AU - Advani, Ranjana H

AU - Brice, Pauline

AU - Bartlett, Nancy L

AU - Rosenblatt, Joseph D

AU - Illidge, Tim

AU - Matous, Jeffrey

AU - Ramchandren, Radhakrishnan

AU - Fanale, Michelle A

AU - Connors, Joseph M.

AU - Fenton, Keenan

AU - Huebner, Dirk

AU - Pinelli, Juan

AU - Shustov, Andrei R.

N1 - 624. Hodgkin Lymphoma and T/NK Cell Lymphoma-Clinical Studies: Poster III | Barbara Pro, Ranjana H Advani, Pauline Brice, Nancy L Bartlett, Joseph D Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle A Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan Pinelli, Andrei R.

PY - 2014/12/6

Y1 - 2014/12/6

UR - https://ashpublications.org/blood/article/128/22/4144/113733/Five-Year-Survival-Data-from-a-Pivotal-Phase-2

U2 - 10.1182/BLOOD.V128.22.4144.4144

DO - 10.1182/BLOOD.V128.22.4144.4144

M3 - Article

VL - 128

JO - Blood

JF - Blood

IS - 22

ER -

Five-Year Survival Data from a Pivotal Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Disciplines

Access to Document

Other files and links

Cite this